NPs Basic Information

Name
Cyclotryprostatin E
Molecular Formula C23H29N3O6
IUPAC Name*
(1S,2S,12S,15S)-1-hydroxy-12-(2-hydroxy-2-methylpropyl)-2,7-dimethoxy-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione
SMILES
CC(C)(C[C@H]1C2=C([C@@H]([C@]3(N1C(=O)[C@@H]4CCCN4C3=O)O)OC)C5=C(N2)C=C(C=C5)OC)O
InChI
InChI=1S/C23H29N3O6/c1-22(2,29)11-16-18-17(13-8-7-12(31-3)10-14(13)24-18)19(32-4)23(30)21(28)25-9-5-6-15(25)20(27)26(16)23/h7-8,10,15-16,19,24,29-30H,5-6,9,11H2,1-4H3/t15-,16-,19-,23-/m0/s1
InChIKey
IQQGHQDLZFLSGU-YZQOHXRLSA-N
Synonyms
Cyclotryprostatin E; CHEMBL2229116; 12beta-hydroxy-13alpha-methoxyverruculogen TR-2
CAS NA
PubChem CID 56954715
ChEMBL ID CHEMBL2229116
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Indoles and derivatives
        • Subclass: Pyridoindoles
          • Direct Parent: Beta carbolines

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 443.5 ALogp: 0.3
HBD: 3 HBA: 6
Rotatable Bonds: 4 Lipinski's rule of five: Accepted
Polar Surface Area: 115.0 Aromatic Rings: 5
Heavy Atoms: 32 QED Weighted: 0.667

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.969 MDCK Permeability: 0.00000895
Pgp-inhibitor: 0.889 Pgp-substrate: 0.155
Human Intestinal Absorption (HIA): 0.033 20% Bioavailability (F20%): 0.01
30% Bioavailability (F30%): 0.785

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.254 Plasma Protein Binding (PPB): 49.04%
Volume Distribution (VD): 1.215 Fu: 40.93%

ADMET: Metabolism

CYP1A2-inhibitor: 0.011 CYP1A2-substrate: 0.118
CYP2C19-inhibitor: 0.104 CYP2C19-substrate: 0.821
CYP2C9-inhibitor: 0.291 CYP2C9-substrate: 0.493
CYP2D6-inhibitor: 0.005 CYP2D6-substrate: 0.184
CYP3A4-inhibitor: 0.43 CYP3A4-substrate: 0.934

ADMET: Excretion

Clearance (CL): 9.001 Half-life (T1/2): 0.322

ADMET: Toxicity

hERG Blockers: 0.008 Human Hepatotoxicity (H-HT): 0.804
Drug-inuced Liver Injury (DILI): 0.987 AMES Toxicity: 0.011
Rat Oral Acute Toxicity: 0.628 Maximum Recommended Daily Dose: 0.961
Skin Sensitization: 0.381 Carcinogencity: 0.127
Eye Corrosion: 0.003 Eye Irritation: 0.008
Respiratory Toxicity: 0.946
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003013 0.840 D06YFA 0.286
ENC003265 0.740 D0J4JM 0.285
ENC001958 0.629 D02IQY 0.278
ENC003264 0.629 D0G8NJ 0.275
ENC000837 0.484 D0C6DT 0.260
ENC001060 0.478 D01XNB 0.260
ENC002274 0.478 D01TSI 0.256
ENC002064 0.469 D0SP3D 0.249
ENC005479 0.466 D09NNH 0.249
ENC002698 0.456 D0V3ZA 0.249
*Note: the compound similarity was calculated by RDKIT.